Therapeutic Potential of Prodrugs Towards Targeted Drug Delivery

Open Med Chem J. 2018 Oct 23:12:111-123. doi: 10.2174/1874104501812010111. eCollection 2018.

Abstract

In designing of Prodrugs, targeting can be achieved in two ways: site-specified drug delivery and site-specific drug bioactivation. Prodrugs can be designed to target specific enzymes or carriers by considering enzyme-substrate specificity or carrier-substrate specificity in order to overcome various undesirable drug properties. There are certain techniques which are used for tumor targeting such as Antibody Directed Enzyme Prodrug Therapy [ADEPT] Gene-Directed Enzyme Prodrug Therapy [GDEPT], Virus Directed Enzyme Prodrug Therapy [VDEPT] and Gene Prodrug Activation Therapy [GPAT]. Our review focuses on the Prodrugs used in site-specific drug delivery system specially on tumor targeting.

Keywords: ADEPT; Cytotoxic; GDEPT; GPAT; NTR; Prodrug; VDEPT; Xenobiotics.

Publication types

  • Review